Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Gross Profit (2018 - 2025)

AVITA Medical's Gross Profit history spans 8 years, with the latest figure at $14.3 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 11.26% year-over-year to $14.3 million; the TTM value through Dec 2025 reached $58.8 million, up 6.63%, while the annual FY2025 figure was $58.8 million, 6.63% up from the prior year.
  • Gross Profit reached $14.3 million in Q4 2025 per RCEL's latest filing, up from $13.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $16.4 million in Q3 2024 to a low of $5.8 million in Q1 2022.
  • Average Gross Profit over 5 years is $10.8 million, with a median of $9.6 million recorded in 2024.
  • Peak YoY movement for Gross Profit: skyrocketed 174.76% in 2021, then fell 15.78% in 2022.
  • A 5-year view of Gross Profit shows it stood at $5.9 million in 2021, then soared by 36.68% to $8.1 million in 2022, then skyrocketed by 52.92% to $12.4 million in 2023, then soared by 30.06% to $16.1 million in 2024, then decreased by 11.26% to $14.3 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Gross Profit are $14.3 million (Q4 2025), $13.9 million (Q3 2025), and $14.9 million (Q2 2025).